Institute of Psychiatry, Kings College London
- Advisory Board: Eli Lilly and Company; Janssen-Cilag International N.V.; Shionogi Pharma, Inc. (formerly Sciele Pharmaceuticals)
- Grant Support: Eli Lilly and Company; Janssen-Cilag International N.V.; Shionogi Pharma, Inc. (formerly Sciele Pharmaceuticals)
- Honorarium for participation in another meeting: Eli Lilly and Company; Janssen-Cilag International N.V.; Shionogi Pharma, Inc. (formerly Sciele Pharmaceuticals)
- Royalties: Cognitive Centre of Canada
- Travel Support for participation in another meeting: Eli Lilly and Company; Janssen-Cilag International N.V.
- Travel Support to attend this meeting: Shionogi Pharma, Inc. (formerly Sciele Pharmaceuticals)
- royalty payment for R&R2 ADHD programme: Cognitive Centre of Canada